← Back to headlines
US FDA Proposes Curbs on Mass Compounding of Weight-Loss Drugs
The U.S. FDA has proposed new restrictions on the mass compounding of weight-loss drugs manufactured by Novo Nordisk and Eli Lilly.
30 Apr, 17:56 — 30 Apr, 17:56
Sources
Showing 1 of 1 sources
Related Stories
MASA Calls for Review of State Support for Belgrade University After Shanghai List Drop
17m ago
Disney Sues FCC Over Alleged Retaliatory ABC License Review
20m ago
Trump Posts Map Claiming Strait of Hormuz as US Territory Amid Iran Tensions
21m ago
Greek Ministry Threatens Legal Action Over Antinero Program Allegations
31m ago